Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 6/20 | 0.59 |
| ▸ | EPHA2 | P29317 | 3/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.59 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | EFNA1 | P20827 | 1/20 | 0.59 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.59 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.59 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.59 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.59 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.59 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.47 |
| ▸ | VDR | P11473 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29470870 | 1.00 | GPBAR1 (0.59) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL4782237 | 1.00 | GPBAR1 (0.59) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL4735727 | 1.00 | GPBAR1 (0.59) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL4734420 | 1.00 | GPBAR1 (0.59) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL4735800 | 1.00 | GPBAR1 (0.59) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL4737071 | 1.00 | GPBAR1 (0.59) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL4740098 | 1.00 | GPBAR1 (0.59) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL4734846 | 1.00 | GPBAR1 (0.59) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL4734955 | 1.00 | GPBAR1 (0.59) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL4735820 | 0.99 | GPBAR1 (0.60) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3973972-B1 | MULTI-SUPPLEMENT COMPOSITIONS | MELALEUCA INC (US) | 2025-08-27 | — | — | EP | disclosed |
| US-20220118064-A1 | MULTI-SUPPLEMENT COMPOSITIONS | MELALEUCA, INC. | 2022-04-21 | — | — | US | disclosed |
| EP-3973972-A1 | MULTI-SUPPLEMENT COMPOSITIONS | Melaleuca, Inc. (US) | 2022-03-30 | — | — | EP | disclosed |
| US-11278553-B2 | Dietary supplement compositions for cardiovascular health | MELALEUCA, INC. (US) | 2022-03-22 | — | — | US | disclosed |
| CN-101472489-A | Homogeneous dispersions containing citrus pulp and applications thereof | CARGILL INC (US) | 2009-07-01 | — | — | CN | disclosed |
| EP-0982315-B1 | Preparation of sterol and stanol esters | MCNEIL PPC INC (US) | 2006-04-12 | — | — | EP | disclosed |
| US-6184397-B1 | LARGE SCALE PRODUCTION OF ESTERS IN HIGH YIELDS BY THE ESTERIFICATION OF STEROLS USING AN ACID OR BASIC CATALYST AND A DECOLORING AGENT; SOLVENT-AND MINERAL ACID-FREE; FOODGRADE; ANTICHOLESTEROL AGENTS, E.G. B-SITOSTEROL FATTY ESTER | MCNEIL-PPC, INC. | 2001-02-06 | — | — | US | disclosed |
| US-6147236-A | Preparation of sterol and stanol-esters | MCNEIL-PPC, INC. (US) | 2000-11-14 | — | — | US | disclosed |
| EP-0982316-A2 | Preparation of sterol and stanol-esters | McNEIL-PPC, INC. (US) | 2000-03-01 | — | — | EP | disclosed |
| EP-0982315-A2 | Preparation of sterol and stanol esters | McNEIL-PPC, INC. (US) | 2000-03-01 | — | — | EP | disclosed |
| US-5892068-A | Preparation of sterol and stanol-esters | MCNEIL-PPC, INC. (US) | 1999-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11278553-B2 | Dietary supplement compositions for cardiovascular health | APOB, FABP3, HDLBP | GPBAR1 185/4885EPHA2 2608/4885HSD17B10 161/4885 |
| US-20220118064-A1 | MULTI-SUPPLEMENT COMPOSITIONS | SLC5A6, FABP2, GLS2 | GPBAR1 1012/4885EPHA2 2953/4885HSD17B10 636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.